These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 32766754)
1. The phenomenal epigenome in neurodevelopmental disorders. Ciptasari U; van Bokhoven H Hum Mol Genet; 2020 Sep; 29(R1):R42-R50. PubMed ID: 32766754 [TBL] [Abstract][Full Text] [Related]
2. Functional annotation of genomic variation: DNA methylation episignatures in neurodevelopmental Mendelian disorders. Sadikovic B; Levy MA; Aref-Eshghi E Hum Mol Genet; 2020 Sep; 29(R1):R27-R32. PubMed ID: 32644126 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation signatures for chromatinopathies: current challenges and future applications. Awamleh Z; Goodman S; Choufani S; Weksberg R Hum Genet; 2024 Apr; 143(4):551-557. PubMed ID: 37022461 [TBL] [Abstract][Full Text] [Related]
4. Five years of experience in the Epigenetics and Chromatin Clinic: what have we learned and where do we go from here? Harris JR; Gao CW; Britton JF; Applegate CD; Bjornsson HT; Fahrner JA Hum Genet; 2024 Apr; 143(4):607-624. PubMed ID: 36952035 [TBL] [Abstract][Full Text] [Related]
5. Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature. Rots D; Chater-Diehl E; Dingemans AJM; Goodman SJ; Siu MT; Cytrynbaum C; Choufani S; Hoang N; Walker S; Awamleh Z; Charkow J; Meyn S; Pfundt R; Rinne T; Gardeitchik T; de Vries BBA; Deden AC; Leenders E; Kwint M; Stumpel CTRM; Stevens SJC; Vermeulen JR; van Harssel JVT; Bosch DGM; van Gassen KLI; van Binsbergen E; de Geus CM; Brackel H; Hempel M; Lessel D; Denecke J; Slavotinek A; Strober J; Crunk A; Folk L; Wentzensen IM; Yang H; Zou F; Millan F; Person R; Xie Y; Liu S; Ousager LB; Larsen M; Schultz-Rogers L; Morava E; Klee EW; Berry IR; Campbell J; Lindstrom K; Pruniski B; Neumeyer AM; Radley JA; Phornphutkul C; Schmidt B; Wilson WG; Õunap K; Reinson K; Pajusalu S; van Haeringen A; Ruivenkamp C; Cuperus R; Santos-Simarro F; Palomares-Bralo M; Pacio-Míguez M; Ritter A; Bhoj E; Tønne E; Tveten K; Cappuccio G; Brunetti-Pierri N; Rowe L; Bunn J; Saenz M; Platzer K; Mertens M; Caluseriu O; Nowaczyk MJM; Cohn RD; Kannu P; Alkhunaizi E; Chitayat D; Scherer SW; Brunner HG; Vissers LELM; Kleefstra T; Koolen DA; Weksberg R Am J Hum Genet; 2021 Jun; 108(6):1053-1068. PubMed ID: 33909990 [TBL] [Abstract][Full Text] [Related]
6. Reprogramming of the epigenome in neurodevelopmental disorders. Wilson KD; Porter EG; Garcia BA Crit Rev Biochem Mol Biol; 2022 Feb; 57(1):73-112. PubMed ID: 34601997 [TBL] [Abstract][Full Text] [Related]
7. Neurodevelopmental disorders with epigenetic dysregulation and Sang Cho K; Song B; Lee IS Front Biosci (Landmark Ed); 2019 Jun; 24(7):1330-1349. PubMed ID: 31136982 [TBL] [Abstract][Full Text] [Related]
8. A critical appraisal of clinical epigenetics. Horsthemke B Clin Epigenetics; 2022 Jul; 14(1):95. PubMed ID: 35902960 [TBL] [Abstract][Full Text] [Related]
10. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes. Gabriele M; Lopez Tobon A; D'Agostino G; Testa G Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):306-327. PubMed ID: 29309830 [TBL] [Abstract][Full Text] [Related]
11. Linking genetics to epigenetics: The role of folate and folate-related pathways in neurodevelopmental disorders. Lintas C Clin Genet; 2019 Feb; 95(2):241-252. PubMed ID: 30047142 [TBL] [Abstract][Full Text] [Related]
12. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Mossink B; Negwer M; Schubert D; Nadif Kasri N Cell Mol Life Sci; 2021 Mar; 78(6):2517-2563. PubMed ID: 33263776 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic priming in neurodevelopmental disorders. Ernst C; Jefri M Trends Mol Med; 2021 Dec; 27(12):1106-1114. PubMed ID: 34690045 [TBL] [Abstract][Full Text] [Related]
14. New gene discoveries highlight functional convergence in autism and related neurodevelopmental disorders. Moyses-Oliveira M; Yadav R; Erdin S; Talkowski ME Curr Opin Genet Dev; 2020 Dec; 65():195-206. PubMed ID: 32846283 [TBL] [Abstract][Full Text] [Related]
15. [Beyond genetics--the emerging role of epigenetics and its clinical aspects]. Urbán S V; Benevolenskaya E; Kiss J; Sági B; Hegyi B; Uher F Orv Hetil; 2012 Feb; 153(6):214-21. PubMed ID: 22296925 [TBL] [Abstract][Full Text] [Related]
16. Introduction into the analysis of high-throughput-sequencing based epigenome data. Huss M Brief Bioinform; 2010 Sep; 11(5):512-23. PubMed ID: 20457755 [TBL] [Abstract][Full Text] [Related]
17. The omics era: a nexus of untapped potential for Mendelian chromatinopathies. Nava AA; Arboleda VA Hum Genet; 2024 Apr; 143(4):475-495. PubMed ID: 37115317 [TBL] [Abstract][Full Text] [Related]
18. Emerging Insights into the Distinctive Neuronal Methylome. Clemens AW; Gabel HW Trends Genet; 2020 Nov; 36(11):816-832. PubMed ID: 32839016 [TBL] [Abstract][Full Text] [Related]
19. A guide to visualizing the spatial epigenome with super-resolution microscopy. Xu J; Liu Y FEBS J; 2019 Aug; 286(16):3095-3109. PubMed ID: 31127980 [TBL] [Abstract][Full Text] [Related]
20. Epigenomics: Roadmap for regulation. Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562 [No Abstract] [Full Text] [Related] [Next] [New Search]